Modulation of limbic noradrenergic circuits by cannabinoids
Year: 2010
Type: dissertation
Abstract: The endocannabinoid system has been implicated in the regulation of several physiological functions. The widespread distribution of the endocannabinoid system in the central nervous system (CNS) accounts for many effects attributed to cannabinoids. Importantly, cannabinoids have been shown to modulate mood, cognition and memory. There is growing evidence suggesting that cannabinoids can interact with the noradrenergic system. Noradrenergic transmission in the CNS has also been implicated in the regulation of mood, cognition and memory. In the present work, the hypothesis that cannabinoids can impact noradrenergic transmission in the limbic system was examined. Firstly, localization of the cannabinoid receptor type 1 (CB1r) was performed in the nucleus accumbens (Acb) and in the nucleus of the solitary tract (NTS), using immunohistochemical techniques, to clarify the anatomical substrates underlying potential interactions. It was shown that CB1r is present in noradrenergic neurons of the NTS. In addition, CB1r was found in the Acb but rarely in noradrenergic terminals. Furthermore, the effects of cannabinoid administration on adrenergic receptor (AR) expression in the Acb were studied. Western blot analysis of accumbal tissue revealed that exogenous administration of the synthetic cannabinoid WIN 55,212-2 decreases α2A- and β1-AR expression. Finally, the importance of norepinephrine (NE) in cannabinoid-induced behaviors was tested. Using the place conditioning paradigm and the elevated zero maze (EZM), the effects of cannabinoids on aversion and anxiety, respectively, were tested following depletion or blockade of noradrenergic transmission in the Acb or in the bed nucleus of the stria terminalis (BNST). Using an immunotoxin approach, NE depletion restricted to the Acb, but not BNST, blocked the expression of aversion to WIN 55,212-2. Depletion of NE had no effect on WIN 55,212-2-induced anxiety. Moreover, the fact that blockade of β1-AR in the Acb prevents WIN 55,212-2-induced aversion suggests that noradrenergic transmission via β1-AR is critical for eliciting this behavior. In conclusion, the present work provides new evidence supporting the idea that cannabinoids can impact noradrenergic transmission in the limbic system. In addition, cannabinoid-induced aversion is dependent on intact noradrenergic transmission in the Acb. Taken together, the studies provide herein clarify the anatomical and neurochemical substrates for cannabinoid actions in the CNS.
Author: Ana Raquel Franky Gomes Carvalho
Institution: University of Minho
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2253522270
